CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company
CytoDyn Inc.
Sign in to watch- Ticker
- CYDY
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- May 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 753056237
- Phone
- 360-980-8524
- Business address
- 1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
- Former names
- CYTODYN INC, REXRAY CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-21 | Mulholland Michael D. Chief Financial Officer | Option exercise | +88,199 | $0.87 | $77K | 873,878 |
| 2020-12-21 | Mulholland Michael D. Chief Financial Officer | Sale | −585,797 | $5.58 | $3.3M | 284,081 |
| 2020-12-21 | Mulholland Michael D. Chief Financial Officer | Option exercise · Non-qualified Stock Option (right to buy) | +201,598 | 0 | ||
| 2020-12-21 | Mulholland Michael D. Chief Financial Officer | Option exercise · Non-qualified Stock Option (right to buy) | +300,000 | 0 | ||
| 2020-12-21 | Mulholland Michael D. Chief Financial Officer | Option exercise · Non-qualified Stock Option (right to buy) | +88,199 | 161,801 | ||
| 2020-12-21 | Mulholland Michael D. Chief Financial Officer | Option exercise | +201,598 | $0.57 | $115K | 485,679 |
| 2020-12-21 | Mulholland Michael D. Chief Financial Officer | Option exercise | +300,000 | $0.80 | $240K | 785,679 |
| 2020-12-21 | Mulholland Michael D. Chief Financial Officer | Option exercise | +88,199 | $0.87 | $77K | 873,878 |
| 2020-12-21 | Mulholland Michael D. Chief Financial Officer | Sale | −589,797 | $5.58 | $3.3M | 284,081 |
| 2020-12-21 | Mulholland Michael D. Chief Financial Officer | Option exercise · Non-qualified Stock Option (right to buy) | +201,598 | 0 | ||
| 2020-12-21 | Mulholland Michael D. Chief Financial Officer | Option exercise · Non-qualified Stock Option (right to buy) | +300,000 | 0 | ||
| 2020-12-21 | Mulholland Michael D. Chief Financial Officer | Option exercise · Non-qualified Stock Option (right to buy) | +88,199 | 161,801 | ||
| 2020-12-18 | Mulholland Michael D. Chief Financial Officer | Option exercise | +155,500 | $0.39 | $61K | 439,581 |
| 2020-12-18 | Mulholland Michael D. Chief Financial Officer | Option exercise | +233,100 | $0.49 | $114K | 672,681 |
| 2020-12-18 | Mulholland Michael D. Chief Financial Officer | Option exercise | +98,402 | $0.57 | $56K | 771,083 |
| 2020-12-18 | Mulholland Michael D. Chief Financial Officer | Sale | −487,002 | $4.95 | $2.4M | 284,081 |
| 2020-12-18 | Mulholland Michael D. Chief Financial Officer | Option exercise · Non-qualified Stock Option (right to buy) | +155,500 | 0 | ||
| 2020-12-18 | Mulholland Michael D. Chief Financial Officer | Option exercise · Non-qualified Stock Option (right to buy) | +233,100 | 116,900 | ||
| 2020-12-18 | Mulholland Michael D. Chief Financial Officer | Option exercise · Non-qualified Stock Option (right to buy) | +98,402 | 201,598 | ||
| 2020-12-18 | Mulholland Michael D. Chief Financial Officer | Option exercise | +155,500 | $0.39 | $61K | 439,581 |
Page 10 of 33 · 652 trades